This activity has expired. Credit is no longer available.
This activity is supported by an independent educational grant from Merck Sharp & Dohme Corp.

Advances in the Management of Patients with Urothelial Carcinomas of the Bladder

Emily Lemke, DNP, AGPCNP-BC, AOCNP®
The University of Texas MD Anderson Cancer Center

Amishi Shah, MD
The University of Texas MD Anderson Cancer Center

Get an update on the state of chemotherapy and immunotherapy for the treatment of urothelial carcinomas of the bladder. Learn how these therapies combat the various types of urothelial carcinomas and how to identify their most common side effects, including immune-related adverse effects from immunotherapy.



 

Download Transcript

 
 

Download Slides


 
These activities, certified for CME/CE/CPE credit, are jointly provided by

Annenberg Logo Harborside Press Logo

in collaboration with

JADPRO CE Logo APSHO Logo
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.